Low performance and the high fouling tendency of Polyetherimide (PEI) membranes prevent their widespread commercial utility. In this study, we utilized a deep eutectic solvent (DES) as a versatile agent for surface modification of the PEI membrane using a simple and sustainable method. To attain an efficient PEI membrane, modeling and optimization of the modification condition were conducted via response surface methodology (RSM).
View Article and Find Full Text PDFStem Cell Res Ther
January 2025
Background: Inflammatory bowel disease (IBD) is a persistent inflammation of the digestive system, and Mesenchymal Stem Cells (MSCs) and their exosomes have demonstrated potential as treatments for this condition. The objective of this research was to examine the possible effectiveness of intraperitoneal injection of umbilical cord-MSCs (UC-MSCs) and their exosomes through a two-time injection regimen in a mouse model.
Method: In this study, an animal model of a specific type of IBD in C57BL/6 mice, induced by dextran sulfate sodium (DSS), was utilized.
Introduction: Cancer is a significant public health issue in Iran, and its incidence has been on the rise in recent years. The objective of this study is to predict the incidence of total cancer in Iran using a Bayesian age-period-cohort (APC) model.
Methods: Utilizing age-period-cohort modeling, this study assessed the multifaceted effects of age, period, and cohort on cancer incidence during the period spanning 2005 to 2017.
This research investigated the sound insulation performance of 3D woven hybrid fabric-reinforced composites using natural fibers, such as jute, along with E-glass and biomass derived from agro-waste, e.g., coffee husk and waste palm fiber.
View Article and Find Full Text PDFPancreatic ductal adenocarcinoma (PDAC) remains as one of the most lethal malignancies. c-MET is an important oncogenic kinase involved in PDAC progression. We determined the anticancer effect of c-MET inhibitors, crizotinib and cabozantinib, combined with chemotherapeutic agents, doxorubicin, oxaliplatin and gemcitabine, against different PDAC and a lung adenocarcinoma cell line expressing different levels of c-MET.
View Article and Find Full Text PDF